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Summary The authors report two cases of Brazilian children with most of the
common syndromic features of Proteus syndrome, such as asymmetric overgrowth of
tissues, skin abnormalities, hypotonia and mental retardation. In both patients, a
refractory epilepsy, compatible with Ohtahara syndrome, as well as hemimegalen-
cephaly, with asymmetric distribution of facial fat, were also diagnosed.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Proteus syndrome is a rare congenital neurocuta-
neous syndrome that was first described in
1979.1 The etiology of Proteus syndrome, initially* Corresponding author at: Rua Ferreira Viana, 865/503, Pet-
ro´polis, CEP 90670-100, Porto Alegre, RS, Brazil.
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doi:10.1016/j.seizure.2007.11.001unknown,2—5 started to be described in 2000, with
studies reporting mutations in the tumor suppressor
gene PTEN.6—8
Clinical manifestations are highly variable, but
usually affect the brain and other tissues.8,9 Main
clinical signs are overgrowth of the brain, hemihy-
pertrophy, gigantismof theextremities, skin abnorm-
alities, multiple hamartomatous tumors and mental
retardation.3,10,11 Brain radiology findings are also
variable, and may include hemimegalencephaly,. Published by Elsevier Ltd. All rights reserved.
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calcifications.12 Finally, epilepsy and epileptic syn-
dromes, often of early onset andhard to control, such
as the Ohtahara syndrome, may be associated.13
Ohtahara syndrome, an early-infantile epileptic
encephalopathy, was first described in 1976,14 and is
characterized by frequent epileptic spasms and EEG
burst suppression patterns, in which suppression
phases usually last longer (up to 10 s) than high
voltage spikes (1—3 s).15—17 Clinical signs include
flexor, extensor, or flexor—extensor spasms, fre-
quently with clustering, that usually last longer than
10 s and occur during sleeping and waking states.
Partial seizures may occur in up to one-third of the
cases.18
The etiology of Ohtahara syndrome is heteroge-
neous and includes central nervous system (CNS)
malformations, such as hemimegalencephaly,19—21
porencephaly, Aicardi syndrome,22 and other con-
ditions.17,23—27
The prognosis is poor due to the intractability of
seizures. Mortality is high, particularly among early-
onset cases, and estimated survival is 2 years.18
This report describes and discusses two cases of
infants seen at Hospital de Clı´nicas de Porto Alegre
and reviews the pertinent literature.Case 1
A female infant born prematurely at 35 weeks’
gestational age by cesarean delivery due to acute
fetal distress was admitted to the neonatal ICU andFigure 1 EEG burst suppressiorequired prolonged mechanical ventilation and
treatment with antibiotics.
The patient, seen at the emergency department
at 4 months of age, had a history of flexor spasms of
the four extremities that started in the 2ndmonth of
life at a frequency of 4—5 episodes/day. Prior to
being admitted at our department, treatment con-
sisted of monotherapy with phenobarbital (from the
second to the 4th month of life).
Examination showed asymmetric syndromic
facies, with the left side larger than the right, head
circumference above the 98th percentile, flexor
hypertonia of the four extremities with hyperre-
flexia, and persistence of neonatal reflexes. Delays
in neurologic and psychomotor development were
also identified.
Fundus examination revealed a pale optic
papilla and peripheral scars. Skin findings included
a flat hemangioma in the occipital region and
a nevus depigmentosus in the left mandibular
region.
Sleep electroencephalogram (EEG) revealed a
high voltage burst suppression pattern with bursts
lasting 1—3 s, slow waves and multifocal spikes at
burst to burst intervals, and prolonged suppression
phases, some of which lasted up to 10 s (Fig. 1).
Flair magnetic resonance imaging (MRI) revealed
left hemimegalencephaly, callosal dysgenesis,
pachygyria and polymicrogyria (Fig. 2).
During follow-up, other anticonvulsant drugs were
administered in an attempt to control seizures. At
discharge, seizures were partially controlled with
valproic acid, primidone, and vigabatrin.n and multifocal paroxysms.
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Figure 2 Flair MRI shows left hemimegalencephaly.Control EEG carried out at 8 months of follow-up
showed disorganized and asymmetric background
rhythms, amplitude attenuation and no sleep spin-
dles. Frequent and predominantly frontotemporal
paroxysms in the left hemisphere and a hypsarrhyth-
mic pattern were also found (Fig. 3).Figure 3 EEG shows left temporal lobe delta activity and mCase 2
A 2-month-old female infant born at full term (38
weeks) by cesarean delivery due to acute fetal
distress and presenting respiratory dysfunction
and sepsis was admitted to the neonatal ICU for 7
days. Initial examination showed facial asymmetry
with marked hypertrophy of right side of face, but
neurologic examination did not reveal any other
abnormal findings.
Cranial tomography showed overgrowth of the
right side of brain, gray matter heterotopia in the
occipital horn of right lateral ventricle, hypoplasia
of the left hemisphere and a hypodense left frontal
area.
Onset of seizures in the 2nd month of life was
characterized by brief epileptic spasms of upper
extremities. Electroencephalogram showed a burst
suppression pattern. Bursts lasted 3—5 s and were
mixed with prolonged bilateral and mildly asym-
metric suppression phases with lower amplitude
to the left.
Valproic acid was initiated and the dose was
gradually increased, but there was no improvement
of seizures. Better control was obtained after the
association of vigabatrin.Discussion
The authors report the cases of two infants with
clinical signs and examination findings suggestive of
Proteus syndrome, a rare hamartomatous syndromeultifocal paroxysms predominantly in left frontal region.
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with hemimegalencephaly.
Hemimegalencephaly has already been reported
in cases of Proteus syndrome, but there is no con-
sensus about its incidence. After the first descrip-
tion of the syndrome,1 several authors have
reported an increasing variability of findings. In
1991, Goodship et al. 28 described associated con-
genital anomalies of the CNS in 12 children with
Proteus syndrome; of these, eight patients showed
evidence of hemimegalencephaly.
In our study, dysmorphic growth, skin abnormal-
ities, CNS malformations and epilepsy were
observed. Onset of epilepsy was in the 2nd month
of life. Epilepsy progressed severely, and Ohtahara
syndrome was diagnosed.
The association of infantile spasms, myoclonias,
and partial epilepsy in newborn infants is generally
observed in cases with extensivemigration disorders
diagnosed as Ohtahara syndrome. Guzzeta et al. 30
reported the case of a male newborn with Ohtahara
syndrome and right hemimegalencephaly who pre-
sented epileptic negative myoclonus on the 1st day
of life. Dietrich et al. 29 described three children
with hemimegalencephaly among eight patients
with early-infantile epileptic encephalopathy with
suppression bursts. In spite of these studies report-
ing the association between Ohtahara syndrome and
hemimegalencephaly, there is no consensus on the
incidence of such occurrence.
Our review of the literature did not yield any
reports of patients with Proteus syndrome asso-
ciated with both hemimegalencephaly and Ohta-
hara syndrome. To our knowledge, these are the
first reports of the triple association, and therefore
it is not possible to describe the incidence of this
association or to make comparisons with the litera-
ture. In addition, our study might suggest that the
occurrence of this triple association is underesti-
mated.
Although prognosis of Proteus syndrome is poor,
treatment approaches such as anticonvulsant med-
ication, physiotherapy, and occupational therapy, in
addition to family support, may be very helpful. On
the other hand, surgical approaches, including
esthetic surgeries and hemispherectomy, should
be further discussed. Specifically regarding hemi-
spherectomy, which is usually suggested in cases of
intractable seizures, we considered this possibility
for both of our cases, but could not reach a con-
sensus among the group.
In view of our findings, and since there is no
consensus regarding the indication of surgery for
hemimegalencephaly, we stress the importance of
adopting a multidisciplinary approach to ensure
early detection of functional disorders, minimizedisabilities, reduce morbidity and mortality. In addi-
tion, we hope these findings increase neurologists’
attention towards the possibility of diagnosing this
triple association.References
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